Evidence map›Paper›PMID 24178124›Full record

ArticleScientific reports2013

Optical imaging to map blood-brain barrier leakage.

Hayder Jaffer, Isaac M Adjei, Vinod Labhasetwar

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 44 citations in OpenAlex.

  1. Catalytic antioxidant nanoparticles mitigate secondary injury progression and promote functional recovery in spinal cord injury model.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Region-specific permeability of the blood-brain barrier upon pericyte loss.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hayder JafferDepartment of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Isaac M Adjei
Vinod Labhasetwar
Cleveland Clinic Lerner College of Medicine · US

Funding

Stroke TherapyR01NS070896 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI LABHASETWAR, VINOD D · 2010 to 2014
$2.3M
Role of Physical Properties in Pharmacokinetics, Biodistribution and Tumor UptakeF31CA150566 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI ADJEI, ISAAC MORRIS · 2010 to 2012
$105k
Howard Hughes Medical InstituteNCI NIH HHS F31 CA150566NCI NIH HHS F31CA150566NINDS NIH HHS 1R01NS070896NINDS NIH HHS R01 NS070896
6 · The paper itself

Abstract

Vascular leakage in the brain is a major complication associated with brain injuries and certain pathological conditions due to disruption of the blood-brain barrier (BBB). We have developed an optical imaging method, based on excitation and emission spectra of Evans Blue dye, that is >1000-fold more sensitive than conventional ultraviolet spectrophotometry. We used a rat thromboembolic stroke model to validate the usefulness of our method for vascular leakage. Optical imaging data show that vascular leakage varies in different areas of the post-stroke brain and that administering tissue plasminogen activator causes further leakage. The new method is quantitative, simple to use, requires no tissue processing, and can map the degree of vascular leakage in different brain locations. The high sensitivity of our method could potentially provide new opportunities to study BBB leakage in different pathological conditions and to test the efficacy of various therapeutic strategies to protect the BBB.

Indexed as

Optical ImagingAnimalsBlood-Brain BarrierBrainColoring AgentsDisease Models, AnimalMalePermeabilityRatsStrokeTissue Plasminogen ActivatorColoring AgentsTissue Plasminogen Activator

Identifiers

PMID24178124
PMCPMC3814906
OpenAlexW2047101776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.